Skip to main content
Equibles

RENAISSANCE TECHNOLOGIES LLC

Position in PDSB — PDS Biotechnology Corp

CIK 1037389 NEW YORK, NY
Back to PDSB Full portfolio

Position in PDSB

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$222,188
+$88,604 QoQ
Shares Held
252,200
+14.2% QoQ
Ownership
0.451%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 52 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PDSB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,950,489,724 across 311 Biotechnology names. PDSB ranks #247 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 EXEL
Exelixis, Inc.
 13,427,993 $730,617,099
2 CORT
Corcept Therapeutics Inc
 5,261,628 $457,498,554
3 INCY
Incyte Corp
 3,512,132 $398,135,283
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 320,008 $158,957,573
5 JAZZ
Jazz Pharmaceuticals plc
 562,073 $135,442,730
6 RPRX
Royalty Pharma plc
 1,935,800 $108,540,306
7 TVTX
Travere Therapeutics, Inc.
 1,833,079 $104,137,217
8 GMAB
Genmab A/S
 3,517,850 $96,635,339

All Filings in PDSB

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $222,188 252,200
2026-03-31 $133,584 220,800
2025-12-31 $136,059 176,700
2025-09-30 $278,619 275,861
2025-06-30 $140,563 105,687
2024-12-31 $163,000 100,000
2024-09-30 $88,624 23,200
2024-03-31 $1,405,008 354,800
2023-12-31 $599,879 120,700
2023-06-30 $114,995 22,862
2023-03-31 $2,249,282 365,737
2022-12-31 $3,264,848 247,337
2022-09-30 $957,302 322,324
2022-06-30 $1,427,285 391,037
2022-03-31 $4,116,579 665,037
2021-12-31 $3,602,369 444,737
2021-09-30 $5,450,971 365,837
2021-06-30 $5,715,985 455,457
2021-03-31 $3,038,248 667,747
2020-12-31 $1,773,462 828,721
2020-09-30 $1,826,386 783,857
2020-06-30 $1,251,570 622,672
2020-03-31 $225,713 309,621